Loading...
Market
What major strategic move will Zepto make post-merger by June 2025?
2
Zepto•National Company Law Tribunal•NCLT•Singapore•Mumbai•Kiranakart•India•Reserve Bank of India•RBI
Resolution / Starting Odds
Launch new product line • 25%
Expand to new markets • 25%
Acquire another company • 25%
No major strategic move • 25%
Company press releases or news reports
Story
Zepto Secures NCLT Approval for Merger with Kiranakart, Completing Flip to India in 30 Days Ahead of IPO
Jan 13, 2025, 04:54 AM
Zepto has received approval from the National Company Law Tribunal (NCLT) to merge its Singapore parent company with its Mumbai-based subsidiary, Kiranakart. This decision facilitates the company's transition back to India, a move aimed at addressing regulatory challenges and enhancing shareholder value. The merger is expected to be completed within the next 30 days, as Zepto prepares for a potential initial public offering (IPO) in India later this year. The NCLT's ruling indicates that the flip will not require approval from the Reserve Bank of India (RBI).
View original story
Similar markets
Takes executive role in a non-streaming company • 25%
Joins another streaming company • 25%
Launches own venture • 25%
No major move announced • 25%
Development of new products • 25%
Expansion into new markets • 25%
Focus on existing products • 25%
No significant changes • 25%
Partnership with cloud services company • 25%
No new partnerships or acquisitions • 25%
Acquisition of a tech startup • 25%
Partnership with AI company • 25%
Cost-cutting and restructuring • 25%
Expansion in Latin America • 25%
Expansion in North America • 25%
Focus on e-commerce growth • 25%
Launch a new product line • 25%
Focus on international expansion • 25%
Other • 25%
Acquire another company • 25%
Partnership with another major retailer • 25%
Expansion into new international markets • 25%
Acquisition of a tech company • 25%
Focusing on sustainability initiatives • 25%
Acquisition by another company • 25%
No major strategic move • 25%
Launch of a new drug development program • 25%
Partnership with another pharmaceutical company • 25%
Divestment of PayPay • 25%
Further investment in PayPay • 25%
Integration with other SoftBank assets • 25%
Other • 25%
No new merger attempts announced • 25%
Announces new merger with another chain • 25%
Pursues smaller acquisitions • 25%
Focuses on internal growth instead • 25%
Expansion of physical stores • 25%
Diversification into new markets • 25%
No significant change • 25%
Focus on online retail • 25%
Other • 25%
Artificial Intelligence Company • 25%
Virtual Reality Company • 25%
Social Media Company • 25%